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Abstract
Introduction
The aims of this study were to describe the key features of acute NHS Trusts with different
levels of research activity and to investigate associations between research activity and
clinical outcomes.
Methods
National Institute for Health Research (NIHR) Comprehensive Clinical Research Network
(CCRN) funding and number of patients recruited to NIHR Clinical Research Network
(CRN) portfolio studies for each NHS Trusts were used as markers of research activity. Pa-
tient-level data for adult non-elective admissions were extracted from the English Hospital
Episode Statistics (2005-10). Risk-adjusted mortality associations between Trust struc-
tures, research activity and, clinical outcomes were investigated.
Results
Low mortality Trusts received greater levels of funding and recruited more patients adjusted
for size of Trust (n = 35, 2,349 £/bed [95% CI 1,855–2,843], 5.9 patients/bed [2.7–9.0]) than
Trusts with expected (n = 63, 1,110 £/bed, [864–1,357] p<0.0001, 2.6 patients/bed [1.7–
3.5] p<0.0169) or, high (n = 42, 930 £/bed [683–1,177] p = 0.0001, 1.8 patients/bed [1.4–
2.1] p<0.0005) mortality rates. The most research active Trusts were those with more doc-
tors, nurses, critical care beds, operating theatres and, made greater use of radiology. Multi-
factorial analysis demonstrated better survival in the top funding and patient recruitment
tertiles (lowest vs. highest (odds ratio & 95% CI: funding 1.050 [1.033–1.068] p<0.0001, re-
cruitment 1.069 [1.052–1.086] p<0.0001), middle vs. highest (funding 1.040 [1.024–1.055]
p<0.0001, recruitment 1.085 [1.070–1.100] p<0.0001).
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Conclusions
Research active Trusts appear to have key differences in composition than less research
active Trusts. Research active Trusts had lower risk-adjusted mortality for acute admis-
sions, which persisted after adjustment for staffing and other structural factors.
Introduction
It is widely assumed that patients cared for in research active institutions have better outcomes
but evidence for this has been limited. The UK National Institute for Health Research (NIHR)
was established in April 2006 to carry forward the vision and goals outlined in the 2005 ‘Best
Research for Best Health’ government white paper.[1] The overall mission of the NIHR is to
create a health research system in which the NHS supports individuals working in world-class
facilities, conducting leading-edge research, focused on the needs of patients and, the public.
One important element in the NIHR’s health research system is the support for, and devel-
opment of, a national Clinical Research Network (CRN). This provides the infrastructure need-
ed to support both patients and healthcare professionals to participate in research activity. Six
NIHR CRNs exist for specific conditions, such as the NIHR Cancer Research Network and the
NIHR Primary Care Research Network. The Comprehensive Clinical Research Network
(CCRN) provides support for research activity that falls outside the scope of the other net-
works. Given its wide remit, the CCRN is responsible for distributing most of the NIHR Clini-
cal Research Network funding, equalling 85% of £285m per annum, underpinning research
activity across a wide range of disciplines. This translates into both direct research time for cli-
nicians and allied health professionals (nurses, pharmacists, radiographers, laboratory staff
etc.) and to research governance support. The level to which the NIHR CCRN supports indi-
vidual Trusts depends, in the main, on their overall research activity.
Whilst the output of NIHR-funded studies is considerable, there are limited data to suggest
a link between research activity and patient outcomes.[2–4] Furthermore, the assessment of
any such association is complex.[5,6] In healthcare systems outside the NHS, there is some evi-
dence that the formation of research networks has associations with improved health out-
comes. For example, in the USA, an analysis of practice-based research networks (PBRNs) in
primary care showed that improved clinical outcomes were apparent for participating prac-
tices, and suggested that this was due to a number of factors, each underpinned by infrastruc-
ture support from the PBRN.[7] Other studies of primary care and oncology networks have
supported this, demonstrating that research networks have “positive and long lasting effects”.
[8,9]
Until recently the availability of data on research activity in NHS Trusts was limited. Since
2010 accurate data has been available of NIHR funding and patient recruitment to studies. The
aims of this study were to utilise this data to address two questions. First, to investigate whether
differences in structural and process factors could be identified between Trusts with varying
levels of research activity. Second, to determine whether any association exists between re-
search activity and mortality outcomes from English NHS Trusts for acute admissions.
Methods
The reporting of this study conforms to the STROBE statement (S1 Appendix).[10]
Research Activity and the Association with Mortality
PLOS ONE | DOI:10.1371/journal.pone.0118253 February 26, 2015 2 / 15
manuscript on the websites but also at http://www.
england.nhs.uk/statistics/statistical-work-areas/.
Funding: Peter Holt is a Clinician Scientist funded
with a personal award by the National Institute for
Health Research (NIHR) (NIHR-CS-011-008), but has
no direct financial involvement with the Comprehensive
Clinical Research Network (CCRN). Jonathan Gower
is employed as the assistant director of the CCRN but
had no influence over the analysis or results. Alan
Karthikesalingam is a Clinical Lecturer supported by
the Circulation Foundation Surgeon Scientist Award.
All other authors have had no support from any
organisation for the submitted work; no other
relationships or, activities that could appear to have
influenced the submitted work. The NIHR had no role
in study design, data collection and analysis, decision
to publish, or preparation of the manuscript. The views
expressed in this publication are those of the authors
and not necessarily those of the NIHR, NHS, or
Department of Health.
Competing Interests: The authors have declared
that no competing interests exist.
Data sources
Three indicators of Trust research activity were utilised, NIHR CCRN funding, number of pa-
tients recruited to NIHR CRN portfolio studies and Trust teaching status. To be eligible for in-
clusion in the portfolio studies must be peer-reviewed, awarded funds through a national
competitive process, of discernable value to the NHS and, of high quality.[11] Funding data
was restricted to the Comprehensive Clinical Research Network. Patient recruitment to portfo-
lio studies included all Clinical Research Networks (comprehensive, primary care, cancer, dia-
betes, medicines for children, stroke, dementia and neurodegenerative diseases and mental
health networks). Research funding data were provided directly by the NIHR CCRN team
from the financial accounts covering the English financial year’s 2010/11.[12] The data com-
prised the total annual funding given to individual NHS Trusts. Number of patients recruited
in 2010/11 to portfolio studies is made publically available by the NIHR annually via The
Guardian newspaper website.[13] English NHS Trusts were classified as teaching hospitals if
they had a direct and specific link with a member of the Medical School Council in England.
[14]
Data on Trust medical staffing numbers, nurse staffing numbers, critical care bed provision,
the use of radiological investigations and, operating theatre number were obtained from the
Health and Social Care Information Centre (HSCIC).[15–17] Trust operational expense data
(as defined by International Financial Reporting Standards) was obtained from trust annual re-
ports. This data was adjusted by the Market Forces Factor which accounts for the particular dif-
ficulties of delivering care in the catchment area covered by that Trust.[18]
Patient-level clinical, demographic, and outcomes data were obtained from the Hospital Ep-
isode Statistics (HES) 1st April 2005–31st March 2010. The HES is an administrative data
warehouse that records the details of every patient admission in England and holds patient-
level data on demographics, co-morbidities and, social deprivation indices. A cohort of patients
admitted non-electively was taken from a previously published study, and encompassed the
breadth of emergency admissions in adults to providers with an acute service.[19] The full de-
tail of case selection and risk models are contained in the prior publication, but, in summary,
patient selection was based on primary diagnostic (ICD-10), or procedural code (OPCS-4) (S1
Table). The primary outcome measure was in-hospital death.
As the focus of this study was to examine the relationships between research activity and
outcome in acute NHS Trusts, those without emergency departments and specialist institu-
tions, such as rheumatological or women’s hospitals, were excluded. The study was restricted
to Trusts in England. Analysis was performed at NHS Trust level (i.e. potentially including
more than one physical site) and the term “Trust” is used synonymously with “hospital”.
Statistical analyses
Analyses were undertaken with SAS version 9.2 (SAS Institute, USA) and R (R Core Team
2013). Trusts were categorised into low mortality, expected mortality and high mortality cate-
gories of risk-adjusted inpatient death. Risk adjustment is described previously and used multi-
level models incorporating patient demographics, comorbidity and social deprivation scores
(based on the patients geographic area of residence) and, a random effects Trust model to ac-
count for clustering of outcomes.[19–23] Statistically significant divergence was defined as
Trusts outlying the 95% confidence interval of the Poisson distribution and Trusts were subse-
quently classified as having mortality rates that were high, as expected or, low. Mean CCRN
funding and 95% confidence intervals were calculated for each of these three strata. Means
were compared with one way ANOVA and Tukey’s range test.[24,25]
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Trusts were categorised into tertiles based on their level of NIHR CCRN research funding
and separately based on number of patients in NIHR CRN portfolio studies. Associations be-
tween these tertiles and mortality was tested in a risk adjusted binary logistic regression model.
Odds ratios and 95% confidence intervals were reported and p<0.05 was
considered significant.
We used two approaches to determine if the association identified could be explained by the
structural or process characteristics of Trusts studied:
1. The unifactorial association of tertile of medical staffing, nurse staffing, critical care beds, ra-
diology utilisation, operating theatres, operational expenses and, teaching status in a risk ad-
justed binary logistic regression model was identified. Variables with p<0.05 were entered
into a multifactorial risk adjusted binary logistic regression model that included tertile of
funding and tertile of patient recruitment.
2. K means clustering was undertaken to categorise Trusts according to the availability or utili-
sation of medical staffing, nurse staffing, critical care beds, radiology utilisation and operat-
ing theatres. After re-scaling each variable partitioning around k-medoids was used to
determine that English NHS Trusts were clustered into two major groups. The structural de-
tails of the two clusters are detailed in Table 1, but can be summarised as trusts characterised
by a greater number of doctors, nurses, critical care beds, operating theatres and, radiodiag-
nostic utilisation (higher resource cluster, n = 23) and those with tendency to less of the
same variables (standard resource cluster, n = 117). The unifactorial association of tertile of
research funding and tertile of patients recruited was re-analysed within each of these
two clusters.
Ethics Statement
The HES data contained in this study was obtained with the necessary pre- requisite permis-
sions from the NHS Information Centre (NHS IC). The local ethics board (Wandsworth Re-
search Ethics Committee) has confirmed that formal ethical approval is not required for HES
extracts as the data source is pseudo-anonymised and publicly available (upon request). The
data was stored on the St George’s University of London secure central server. Although the
data are pseudo-anonymised, they fall under the regulation of the Data Protection Act and
thus permission has been obtained by the Department of Outcomes Research from the local
Caldicott Guardian to store and analyse the data. We did not have direct access to patient
notes/records. Informed consent is not obtained from patients included in the study as the data
available is pseudo-anonymised and we therefore cannot identify individual patients, though
we can track patients through care spells.
Table 1. Structures and processes of NHS trusts as categorised by K means cluster analysis.
Higher Resourced Cluster Standard Resourced Cluster
Doctors /bed 0.82 (0.37) 0.58 (0.13)
Nurses /bed 2.4 (0.51) 1.9 (0.30)
Critical care beds /bed 0.039 (0.029) 0.020 (0.007)
Radiodiagnostic procedures /bed 106 (29) 79 (19)
Operating theatres /bed 0.026 (0.004) 0.022 (0.006)
Values in brackets are interquartile ranges.
doi:10.1371/journal.pone.0118253.t001
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Results
156 trusts were identified of which 140 were suitable for inclusion in the analysis. There was
wide variation in the overall NIHR CCRN funding (median £1,297,801, IQR £1,039,015), num-
ber of study patients (median 1070, IQR 2300), scaled NIHR CCRN funding (median £1,002/
bed, IQR £1,281/bed) and, scaled study patients median (1.8, IQR 2.2) allocated to individual
NHS Trusts (Table 2). Trusts in the top tertile of CCRN funding had or utilised greater levels
of resource relative to Trust size than Trusts attracting lower levels of CCRN funding (Table 3).
Trusts in the top tertile of patient recruitment had greater number of medical and nursing staff
as well as critical care beds than trusts with lower levels of recruitment (Table 4).
Acute admission analysis
The dataset comprised 2,349,160 adult acute admissions to English NHS trusts in the five-year
period. Of these, 1,852,827 were emergency medical admissions and 496,333 emergency surgi-
cal admissions. The crude inpatient mortality rate was 15.3% (further demographic details in
Table 2. Total and scaled NIHR CCRN core research funding and patients recruited to NIHR CRN portfolio studies spread data.
Minimum 1st Quartile Median 3rd Quartile Maximum
CCRN core funding (£) 52,977 379,385 637,926 1,418,400 7,207,747
Scaled CCRN core funding (£/bed) 131 618 1,002 1,899 6,780
Patients recruited CRN portfolio studies 11 628 1070 2928 69260
Scaled patients recruited CRN portfolio studies 0.0139 1.1030 1.795 3.3020 56.1600
Scaled data were calculated £/bed or patient/bed using published Department of Health bed availability data for individual Trusts.
doi:10.1371/journal.pone.0118253.t002
Table 3. Trust structures and processes by tertile of CCRN research funding/trust bed.
Trust NIHR CCRN Funding Level
Lowest Tertile of funding (n = 46)
(95% conﬁdence interval)
Middle Tertile of funding (n = 47)
(95% conﬁdence interval)
Highest Tertile of funding (n = 47)
(95% conﬁdence interval)
Total Trust Beds 687 (592–782) 774 (676–871) 970 (853–1,087)
Research
Measures
Total CCRN Funding
(£)
326,652 (274,920–378,383) 724,159 (623,500–824,818) 2,852,840 (2,306,265–3,399,415)
CCRN Scaled Funding
(£/bed)
507 (463–550) 1,028 (969–1,086) 3,033 (2,610–3,455)
Teaching hospitals n
(%)
7% 6% 38%
Stafﬁng Doctors /bed 0.57 (0.54–0.60) p<0.0001 0.57 (0.54–0.60) p<0.0001 0.79 (0.73–0.85)
Nurses & HCAs /bed 1.9 (1.83–1.97) p<0.0001 1.83 (1.76–1.90) p<0.0001 2.19 (2.08–2.30)
Other Structural
Measures
Critical care beds /bed 0.020 (0.018–0.021) p<0.0001 0.022 (0.020–0.024) p<0.0001 0.033 (0.028–0.038)
Operating Theatres
/bed
0.022 (0.021–0.024) p = 0.0629 0.021 (0.020–0.022) p = 0.0011 0.025 (0.023–0.026)
Radiodiagnostic
procedures /bed
83.33 (76.70–89.95) p = 0.0596 81.37 (76.85–85.88) p = 0.0156 92.66 (86.65–98.67)
Tukey’s range test was utilised to identify whether differences between tertiles was statistically signiﬁcant. P values are for differences with the top tertile.
Trusts in the highest tertile of funding consistently had, or used, greater resources than trusts in the middle and lowest tertile. No signiﬁcant differences
between the lowest and middle tertile of funding.
doi:10.1371/journal.pone.0118253.t003
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S2 Table). The total number of patients included is slightly smaller than in our previous study
using the same patient definitions, as, due to mergers/closures, 2010/11 research funding data
was restricted to fewer trusts. Low mortality outlying Trusts (n = 35, 2600 £/bed, CI 2045–
3154) had higher research network funding than Trusts with expected (n = 63,1278 £/bed, CI
959–1597, p<0.0001) or high outlying mortality (n = 42, 987 £/bed, CI 778–1196, p<0.0001)
(Fig. 1). Low mortality outlying Trusts (n = 35, 5.9 /bed, CI 2.7–9.0) had more patients re-
cruited than Trusts with expected (n = 63, 2.6 /bed, CI 1.7–3.5, p<0.0169) or high outlying
mortality (n = 42, 1.8 /bed, CI 1.4–2.1, p<0.0005).
When Trusts were arranged in tertiles of research funding, patients treated in Trusts in the
lowest (1.156 [1.144–1.168] p<0.0001) and middle (1.135 [1.123–1.147] p<0.0001) tertiles had
higher odds of death than those in the top tertile (Table 5). Trusts in the lower tertiles of medi-
cal staffing, nurse staffing, critical care beds, radiodiagnostic utilisation, operating theatres, op-
erational expenditure and, teaching hospitals also had higher odds ratios for inpatient death
(Table 5).
In multivariate analysis, incorporating research funding, medical staffing, nurse staffing,
critical care beds, radiodiagnostic utilisation, operating theatres, operational expenditure and,
teaching hospital status, the association between research funding and mortality (lowest versus
highest tertile (1.050 [1.033–1.068] p<0.0001), middle versus highest tertile (1.040 [1.024–
1.055] p<0.0001)) as well as patient recruitment and mortality persisted (lowest versus highest
tertile (1.069 [1.052–1.086] p<0.0001), middle versus highest tertile (1.085 [1.070–1.100]
p<0.0001)) (Table 5). The goodness of fit for the multifactorial model was good with a c-statis-
tic (area under the receiver operating characteristic curve) of 0.81.[26] When the analysis was
restricted to the standard resource cluster, Trusts in the low (funding 1.147 [1.134–1.160]
p<0.0001, recruitment 1.075 [1.063–1.086]) and middle tertiles (funding 1.122 [1.110–1.135]
p<0.0001, recruitment 1.072 [1.060–1.083]) of research funding (Fig. 2) and, patients recruited
had higher risk-adjusted odds ratios for inpatient death than the highest tertiles. In the high re-
source cluster, Trusts in the low tertile of research funding (1.223 [1.189–1.258] p<0.0001)
Table 4. Trust structures and processes by tertile of patients recruited to NIHR CRN portfolio studies/trust bed.
Trust Patient Recruitment to NIHR CRN Portfolio Studies
Lowest Tertile of patients
recruited/bed (n = 46) (95%
conﬁdence interval)
Middle Tertile of patients
recruited/bed (n = 47) (95%
conﬁdence interval)
Highest Tertile of patients
recruited/bed (n = 47) (95%
conﬁdence interval)
Total Trust Beds 678 (593–763) 645 (570–719) 890 (780–1001)
Research
Measures
Patients recruited 543 (449–638) 1218 (1023–1413) 6488 (3577–9398)
Scaled number of
patients recruited (/bed)
0.80 (0.70–0.90) 1.85 (1.73–1.97) 6.87 (4.47–9.26)
Teaching hospitals n (%) 0% 10% 44%
Stafﬁng Doctors /bed 0.64 (0.61–0.67) p<0.0001 0.69 (0.65–0.72) p<0.0001 0.87 (0.80–0.93)
Nurses & HCAs /bed 1.7 (1.6–1.7) p<0.0001 1.8 (1.7–1.8) p<0.0001 2.1 (2.0–2.2)
Other Structural
Measures
Critical care beds /bed 0.021 (0.019–0.023) p = 0.0047 0.021(0.019–0.023) p = 0.0061 0.026 (0.023–0.029)
Operating Theatres /bed 0.025 (0.024–0.027) p = 0.0990 0.026 (0.024–0.028) p = 0.1928 0.028 (0.026–0.029)
Radiodiagnostic
procedures /bed
108 (101–114) p = 0.0823 120 (112–128) p = 0.9946 119 (111–128)
Tukey’s range test was utilised to identify whether differences between tertiles was statistically signiﬁcant. P values are for differences with the top tertile.
Trusts in the highest tertile of patient recruitment had, or used, greater resources than trusts in the middle and lowest tertile. No signiﬁcant differences
between the lowest and middle tertile of recruitment though for radiodiagnostic procedures p = 0.0656.
doi:10.1371/journal.pone.0118253.t004
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(Fig. 3), patient recruitment (1.130 [1.118–1.141]) and, middle tertile of patient recruitment
(1.115 [1.104–1.126]) had higher risk-adjusted odds ratios for inpatient death than the
highest tertiles.
Discussion
This study characterises differences in the structures and processes of care between trusts with
differential levels of research activity. The most research active Trusts tend, relative to their size
to be better staffed in terms of doctors and nurses, have more critical care beds and operating
theatres and, have a greater utilisation of advanced radiodiagnostics. Trusts with the best emer-
gency mortality outcomes were those that were most research active. The risk adjusted odds of
death was lower in research active Trusts but also Trusts with more of other resources. The as-
sociation of research activity with outcome could not be explained by staffing, critical care and
operating theatre provision or, radiodiagnostic utilisation as the association persisted in the
multifactorial models and analysis within clusters of resource.
In multi-level modelling the association of both research funding and number of patients re-
cruited to studies to outcome was independent to teaching hospital status. These findings were
consistent with previous work demonstrating no direct relationship between teaching status
and healthcare outcomes, but that the number of citations attributable to a trust was correlated
with Hospital Standardised Mortality Ratios (HSMR).[27,28]
Fig 1. NIHR CCRN funding (£/bed) in English acute NHS Trusts with Trusts sub-grouped as low (n = 35), as expected (n = 63) and, high (n = 42)
mortality. For each group, the mean and 95%CI funding are shown. The low mortality Trusts had significantly higher levels of CCRN funding than the as
expected (p<0.0001) or high (p = 0.0001) mortality Trusts.
doi:10.1371/journal.pone.0118253.g001
Research Activity and the Association with Mortality
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Whilst there is a plausible link between research engagement and healthcare performance,
little empirical evidence currently exists to support this. In particular it has been suggested that
research engagement could improve the processes and outcomes of care. These results support
this possibility, with research activity being associated with outcomes for acute admissions,
rather than being limited only to research participants.
Jarman et al. has previously identified medical staffing to be the best predictor of outcomes
for emergency admissions in 1999 but did not include a measure of research activity beyond
teaching status.[29] This study demonstrated statistically significant associations independent
of teaching status, staffing and, a number of other hospital structures and process.
Table 5. Unifactorial and multifactorial associations of tertile of Trust research funding, patient recruitment to studies, structures and processes
with risk adjusted mortality.
Unifactorial Multifactorial
Resource measure by tertile Odds Ratio of Death (Conﬁdence interval) Odds Ratio of Death (Conﬁdence interval)
Research funding Lowest 1.156 (1.144–1.168) p<0.0001 1.050 (1.033–1.068) p<0.0001
Middle 1.135 (1.123–1.147) p<0.0001 1.040 (1.024–1.055) p<0.0001
Highest 1 1
Lowest 1.056 (1.043–1.068) p<0.0001 1.069 (1.052–1.086) p<0.0001
Patients recruited to studies Middle 1.056 (1.044–1.069) p<0.0001 1.085 (1.070–1.100) p<0.0001
Highest 1 1
Total doctor stafﬁng Lowest 1.152 (1.140–1.164) p<0.0001 1.089 (1.069–1.109) p<0.0001
Middle 1.098 (1.086–1.109) p<0.0001 1.061 (1.047–1.076) p<0.0001
Highest 1 1
Total nurse stafﬁng Lowest 1.100 (1.089–1.112) p<0.0001 0.960 (0.944–0.975) p<0.0001
Middle 1.038 (1.028–1.048) p<0.0001 0.985 (0.973–0.998) p = 0.0001
Highest 1 1
Total critical care beds Lowest 1.060 (1.050–1.072) p<0.0001 0.964 (0.951–0.978) p<0.0001
Middle 1.065 (1.054–1.076) p<0.0001 1.006 (0.993–1.020) p = 0.3888
Highest 1 1
Total radiodiagnostics Lowest 1.096 (1.086–1.107) p<0.0001 1.036 (1.022–1.050) p<0.0001
Middle 1.068 (1.058–1.079) p<0.0001 1.055 (1.043–1.067) p<0.0001
Highest 1 1
Operating theatres Lowest 1.129 (1.119–1.140) p<0.0001 1.064 (1.049–1.079) p<0.0001
Middle 1.084 (1.073–1.094) p<0.0001 1.034 (1.022–1.047) p<0.0001
Highest 1 1
Operational expenditure Lowest 1.158 (1.146–1.170) p<0.0001 1.044 (1.028–1.061) p<0.0001
Middle 1.093 (1.082–1.104) p<0.0001 1.012 (0.999–1.026) p = 0.0792
Highest 1 1
Teaching hospital status Non-teaching 1.076 (1.066–1.086) p<0.0001 0.956 (0.942–0.971) p<0.0001
Teaching 1 1
Of note the association between research funding, patient recruitment and mortality persists in the multifactorial model. The goodness of ﬁt c-statistic
(area under the receiver operating characteristic curve) for the multifactorial model is 0.81.
doi:10.1371/journal.pone.0118253.t005
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In terms of understanding these associations, a recent systematic review suggested that en-
gagement with research by individuals and healthcare organisations increased the likelihood of
a positive impact on healthcare performance.[4] The number of studies was small, but possible
mechanisms for better outcomes included beneficial changes in institutional structure and
human capital, specific processes of care related to conducting trials, improvements in organi-
sational mechanisms, and greater levels of collaboration between organisations, teams and, in-
dividuals. The review concluded that there was “cumulative evidence that organisations in
Fig 2. Risk adjusted odds ratio of inpatient death in English NHS Trusts by tertile of scaled CCRN funding. The analysis is restricted to standard
resource trusts. For each group, the mean and 95%CI are shown. Trusts in the lowest and middle funding tertile had significantly higher mortality relative to
the highest funded trusts.
doi:10.1371/journal.pone.0118253.g002
Research Activity and the Association with Mortality
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which the research function is fully integrated into the organisational structure can out-per-
form other organisations that pay less formal heed to research and its outputs,” which is sup-
ported by these findings.
A benefit extending beyond direct research participants has been noted previously, and was
reinforced by these pan-provider results. One possible explanation is that some attributes of
the setting in which care is delivered, such as equipment and personnel, which are brought in
to perform research may remain in place after the research is completed.[30] Furthermore it
Fig 3. Risk adjusted odds ratio of inpatient death in English NHS Trusts by tertile of scaled CCRN funding. The analysis is restricted to higher
resource trusts. For each group, the mean and 95%CI are shown. Trusts in the lowest funding tertile had significantly higher mortality relative to the highest
funded trusts.
doi:10.1371/journal.pone.0118253.g003
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has been suggested that patients in research active hospitals may have better outcomes than pa-
tients in poorly research-active hospitals because greater research participation leads to accu-
mulated knowledge, develops infrastructure and, brings in resources that can be used to
improve clinical care.[31,32] This broader impact observed in hospitals with greater network
support is supported by three previous studies.[33–35] The suggestion was that hospitals with-
in research networks implement research findings more easily and more quickly, and that clini-
cians were more likely to adopt evidence-based practice and, follow up-to-date clinical
guidelines.
Finally, an American oncological study suggested that greater network involvement was of
greater importance than teaching hospital status in the adoption of new and novel treatments,
which is commensurate with these results.[34] The reason suggested for this were that research
networks act at the interface of research and quality improvement, with networks evolving into
learning communities, providing grounds for generalisable solutions to clinical problems.
[36,37]
Strengths and limitations
In terms of determining the reproducibility of these results, a number of different datasets were
employed in the analyses, drawn from a number of sources and encompassing different infor-
mation. The NIHR CCRN funding and recruitment data were provided by the NIHR from
their own financial accounts and are accurate for individual trusts. Trust level structure and
process data were taken from external datasets, used by the Department of Health for regulato-
ry purposes.
The definition of teaching hospital that we utilised is a traditional one. It should be noted
that the majority of district general Trusts in England are involved in teaching both doctors in
training and, particularly in recent years increasing numbers of medical students.
We modelled risk adjusted mortality around adult acute admissions over a five-year period,
using established methods.[19,38] Risk-standardisation used hierarchical models to account
for clustering of deaths, and included widely validated factors.[39–41] The ascertainment of
the mortality outcomes from the ONS Registry data adds strength to these results. A further
strength of the analysis is the case selection of a group of commonly encountered pathologies
ensuring that the link between mortality and quality is plausible as the conditions are amenable
to salvage. For example the colorectal laparotomy group only included patients undergoing
surgery therefore effectively excluding moribund patients or those with extensive disseminated
disease judged to be unfit or inappropriate for surgery. Previous work has identified that mor-
tality metrics calculated using a restricted group of pathologies reduces over-dispersion of data
and therefore is superior for comparative statistics.[42] Nevertheless highly specialised or ter-
tiary referral centres often have a high percentage of research active clinical academics and also
regional referral intakes with sicker or more complex patients. It is possible therefore that the
most physiologically unwell patients (for example in myocardial infarction or pancreatitis)
may be cared for in research active units. This would if anything however weaken the associa-
tion of research activity with better mortality outcomes. It may however explain the unexpected
finding in the multifactorial analysis that trusts in the lowest tertile of nurse staffing and critical
care provision had more favourable emergency mortality outcomes. Medical staffing and nurse
staffing are highly correlated in the English NHS (Spearman rank correlation coefficient of
0.81). Further secondary modelling with an interaction term between medical and nurse staff-
ing demonstrates an interaction but the association with research activity remain (results not
shown). It may be that the impact of staffing is complex and needs further separate analysis but
this was not pursued, as it is not within the aims of this paper.
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We characterised the categories of research funding in terms of a number of hospital struc-
tures and processes. We considered the possibility that these were confounders of the associa-
tion of funding or recruited patient with outcome in our statistical analysis, but the association
persisted. The possibility remains however of endogenity due to omitted co-factors. Future re-
search will need to assess further the interaction of infrastructure with research activity. The
aim of our study however was not to prove causality between funding or recruited patient num-
ber with outcome. Both were used as surrogates for research activity. Although we controlled
for a number of important factors it seems likely that other unmeasured confounders (re-
sources) could influence outcome. Inverse causality is also a possibility wherein better-
resourced hospitals with better outcomes attract research funding and therefore research ac-
tive. It is of note however that in our sensitivity analysis research funding and recruitment were
associated with outcome even in the higher resource cluster of trusts. There may be organisa-
tional, administrative or managerial factors which impact on a Trusts ability to gain research
funding, recruit patients to studies as well as patient care. This could therefore confound the re-
lationship between research activity and outcome. Accurate funding and patient recruitment
data prior to 2010/2011 was not available. Future research should study longitudinal trends in
research activity, potential confounders and outcome. Such an analysis would better help to
understand the mechanisms (whether causal or confounded) behind the association of research
activity with outcome.
This work was limited by the use of only a single measure of research funding, NIHR CCRN
core funding, and a focus on mortality as an outcome. Determining the association of the larg-
est national funding stream on a hard, validated outcome measure would appear an intuitive
starting position in a detailed examination of measuring the success of national research infra-
structure. Future research should include measures of morbidity and patient reported outcome
measures. More granular information with details of multiple funding streams would provide a
clearer picture of how and where the greatest gains in outcome have been made. It was not pos-
sible to include a measure of research funding by industry, which can account for a significant
proportion of activity in some trusts, as such data is not readily available in the United King-
dom. It is therefore plausible that the associations observed are secondary to alternative re-
search funding streams. This would not however detract from the observation that research
activity associates with clinical outcomes. Future research should investigate whether the type
of studies to which Trusts recruit (interventional versus observational) is associated with differ-
ences in outcome. Accurate data for the type of study was not available for 2010/2011 but is
now being collected and being made publically available. In addition, non-mortality outcomes
should be investigated where data exist on a national scale.
Conclusions
This study provides evidence that research activity in acute English NHS Trusts is associated
with lower mortality outcomes for emergency admissions. The reasons for this is not fully es-
tablished. These results should act as a catalyst to understand the relationships in more detail
with scope for further quantitative analyses.
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